Default: International Journal of Oncology

ISSN: 1019-6439

Journal Home

Journal Guideline

International Journal of Oncology Q2 Unclaimed

Spandidos Publications Greece
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 139. It has an SJR impact factor of 1,099 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,099.

International Journal of Oncology focuses its scope in these topics and keywords: cancer, human, activity, anticancer, cell, tumor, cells, apoptosis, breast, tlr, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

- €

Non OA


International Journal of Oncology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

cancer, human, activity, anticancer, cell, tumor, cells, apoptosis, breast, tlr, caspase, cellsanticancer, component, construct, cytokine, cytostatic, carboxyterminal, bullfrog, brazilian, actioncombination, activation, active, augments, autophagy, baicalensis, binding, bioinformatics, biological, biotinylation,

Best articles by citations

Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E2 synthesis in AGS human gastric cancer cells

View more

Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines

View more

Identification of potential targets for differentiation in human leukemia cells induced by diallyl disulfide

View more

Viral infections as a cause of cancer (Review)

View more

KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer

View more

Protein kinase C-?e´ isoform mediates lysosome labilization in DNA damage-induced apoptosis

View more

Development of a drug resistance model for hepatoblastoma

View more

Spermine accelerates hypoxia-initiated cancer cell migration

View more

Role of cyclinT/Cdk9 complex in basal and regulated transcription (Review)

View more

Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression

View more

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

View more

Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

View more

Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma

View more

Tea in chemoprevention of cancer

View more

Evidence of involvement of the PLAG1 gene in lipoblastomas.

View more

Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer

View more

The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (A review)

View more

Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer

View more

Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1

View more

Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus.

View more

Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor

View more

Hypermethylation of p16INK4a and p15INK4b genes in non-small cell lung cancer

View more

A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line

View more

SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway

View more